Site Search
Professionals 212 results
Capabilities 50 results
Industry
Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations.
Practice Area
Our Patent Litigation Practice is one of the country’s most active and highly regarded. Our seasoned patent litigators bring extensive courtroom experience to every matter we handle. According to Lex Machina, we are among the top three national patent defense firms in the country for number of appearances and cases filed, and we also were the top national defense firm for number of patent trials in the last five years (2018–2022).
Experience 36 results
Experience
|April 29, 2024
Winston advised the partners of BCF Life Sciences Group in its sale to Sparkfood
Experience
|April 10, 2024
Winston assists Eurazeo in the financing of Vulcain Ingénierie's fourth LBO
Experience
|January 19, 2024
Insights & News 935 results
Speaking Engagement
|June 20, 2024
Winston & Strawn partner Kurt Mathas will speak at the 15thSummit on Biosimilars & Innovator Biologics, June 20-21, 2024, in New York. The summit—which attracts the “who’s who” of the industry, including leading in-house counsel from branded and biosimilar companies, representatives from key government agencies, and the top patent and regulatory attorneys—will cover legal, regulatory, and commercial strategies for the innovator and biosimilars marketplace.
Seminar/CLE
|June 4, 2024
2024 Health Care & Life Sciences Summit
Winston & Strawn is pleased to host our Annual Health Care & Life Sciences Summit on Tuesday, June 4, 2024, both virtually and in person in our Chicago office.
Seminar/CLE
|May 9, 2024
Winston’s Product & Mass Torts Summit Series 2024
Winston & Strawn is pleased to kick off our Product & Mass Tort Summit—a series of panels to be presented in key U.S. markets. The first one-hour CLE panel in the series will bring together Winston partners along with in-house counsel Bill Childs (Solventum) and David Mendelson (Abbott Laboratories) to dig into practical and actionable considerations for corporate counsel in managing product liability and mass tort cases.
Other Results 44 results
Law Glossary
Passed in 1998 and implemented in 2000, the Digital Millennium Copyright Act (DMCA) updated U.S. law to meet the requirements of international copyright treaties. The DMCA addresses challenging issues relating to uses of copyrighted material in the digital environment: it limits the liability of online service providers that meet certain conditions, while providing certain procedures for addressing online infringement; it prohibits circumvention of digital technologies that control or limit access to copyrighted works; and it prohibits the removal or modification of certain types of copyright management information contained in protected works. Title II of the DMCA (sometimes also referred to as the Online Copyright Infringement Liability Limitation Act, or OCILLA) is codified at Section 512, Title 17, of the United States Code.
Law Glossary
Emerging technology is a term generally used to describe a new technology, but it may also refer to the continuing development of an existing technology; it can have slightly different meaning when used in different areas, such as media, business, science, or education. The term commonly refers to technologies that are currently developing, or that are expected to be available within the next five to ten years, and is usually reserved for technologies that are creating, or are expected to create, significant social or economic effects.
Law Glossary
Dark patterns are deceptive or manipulative designs on digital platforms that trick users into making unintended choices. Dark patterns can appear as designs that create misleading impressions, hide or delay disclosure of material information, lead to unauthorized charges, or obscure privacy choices. Some examples include advertisements deceptively formatted to look like independent editorial content; non-descriptive dropdowns, arrows, or small icons to hide the full cost and other terms, free trials that automatically convert to recurring subscriptions; and prominent cookie-consent banners that hide cookie-rejection options.